Skip to main content
. 2022 Aug 24;10(9):1375. doi: 10.3390/vaccines10091375

Table 5.

Relative risk of comorbidities of pneumococcal pneumonia and IPD in adolescents and adults ≥ 15 years of age in Liguria, Italy (2012–2018).

Age (Years) Pneumococcal Pneumonia Invasive Pneumococcal Disease
Relative Risk (95% CI) p-Value Relative Risk (95% CI) p-Value
Chronic obstructive pulmonary disease
15–19 7.39 (0.77–71.00) 0.16 0.00 (–)
20–39 6.39 (2.70–15.09) <0.01 2.97 (0.71–12.45) 0.15
40–64 6.91 (4.56–10.49) <0.01 4.22 (2.26–7.85) <0.01
65–84 7.40 (6.04–9.05) <0.01 2.72 (1.83–4.04) <0.01
≥85 5.41 (4.10–7.15) <0.01 4.28 (2.13–8.60) <0.01
Cardiovascular diseases
15–19 0.00 (–) 0.00 (–)
20–39 7.78 (1.89–32.13) <0.01 5.77 (0.79–42.36) 0.16
40–64 6.22 (4.26–9.09) <0.01 11.84 (7.95–17.64) <0.01
65–84 5.90 (4.88–7.15) <0.01 3.22 (2.41–4.30) <0.01
≥85 10.11 (7.10–14.38) <0.01 7.79 (3.58–16.95) <0.01
Diabetes
15–19 115.82 (12.05–1112.71) 0.011 0.00 (–)
20–39 4.50 (0.62–32.68) 0.20 22.01 (6.68–72.55) <0.01
40–64 8.13 (5.59–11.82) <0.01 3.58 (1.92–6.67) <0.01
65–84 1.89 (1.50–2.38) <0.01 1.72 (1.20–2.45) <0.01
≥85 2.04 (1.49–2.80) <0.01 1.83 (0.84–3.97) 0.12
Chronic renal injuries
20–39 20.33 (2.80–147.51) 0.05 0.00 (–)
40–64 8.52 (3.77–19.23) <0.01 15.66 (7.29–33.64) <0.01
65–84 5.40 (4.04–7.21) <0.01 5.88 (3.86–8.95) <0.01
≥85 6.24 (4.68–8.32) <0.01 5.12 (2.49–10.5) <0.01
Neoplasia
15–19 0.00 (–) 0.00 (–)
20–39 2.04 (0.28–14.83) 0.39 0.00 (–)
40–64 2.96 (1.84–4.77) <0.01 4.55 (2.75–7.52) <0.01
65–84 3.35 (2.74–4.11) <0.01 3.63 (2.69–4.91) <0.01
≥85 1.39 (0.97–1.99) 0.08 1.09 (0.43–2.80) 0.80

All data were calculated by univariate analysis. Application of Fisher’s exact test for <5 cases reported. CI: confidence interval; IPD: invasive pneumococcal disease.